GlassScriptPhysician profile
Casey C Carter
NPI 1225406077
$1,366.73
in general payments reported to CMS, 2019-2025
19 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $178 · 2022: $238 · 2023: $496 · 2024: $261 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.27 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $305.78 | 2021-2025 | |
| Harmony Biosciences LLC | $201.41 | 2022-2024 | Wakix |
| Lilly USA, LLC | $154.27 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $131.41 | 2021-2025 | Rybelsus, Ozempic |
| Axsome Therapeutics, INC. | $112.81 | 2022-2025 | Sunosi |
| Astellas Pharma US INC | $71.13 | 2024 | Veozah |
| Inspire Medical Systems, INC. | $54.51 | 2023 | Inspire |
| Abbott Laboratories | $52.76 | 2022-2023 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $40.19 | 2022-2023 | Quviviq |
| Dexcom, INC. | $36.13 | 2021 | |
| Verona Pharma, INC. | $35.14 | 2025 | Ohtuvayre |
| Corcept Therapeutics | $31.28 | 2024 | Korlym |
| Itamar Medical INC | $27.99 | 2023 | Watchpatone |
| Biohaven Pharmaceutical Holding Company LTD. | $27.48 | 2022 | |
| Jazz Pharmaceuticals INC. | $26.83 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.20 | 2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $15.44 | 2024 | Airsupra |
| Allergan, INC. | $13.96 | 2021 | |
| Medtronic, INC. | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.